No Picture
News

Trovagene to Present New Clinical Data for Onvansertib in Metastatic KRAS-Mutated Colorectal Cancer at ASCO 2020 Gastrointestinal Cancers Symposium

SAN DIEGO, Jan. 21, 2020 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, oncology therapeutics company developing onvansertib for the treatment of various cancers including colorectal, prostate and leukemia, today announced that a… […]

No Picture
News

Revolution Medicines to Present Preliminary Data from Phase 1 Clinical Trial of RMC-4630 at 6th AACR-IASLC International Joint Conference

Podium and Poster Presentations to Highlight Initial Findings from Monotherapy Study of Investigational SHP2 Inhibitor, RMC-4630Additional Poster Presentation to Report New Preclinical Results for Company’s Novel Inhibitors of Oncogenic RAS(ON) mutants… […]

No Picture
News

Revolution Medicines to Present Preliminary Data from Phase 1 Clinical Trial of RMC-4630 at 6th AACR-IASLC International Joint Conference

Podium and Poster Presentations to Highlight Initial Findings from Monotherapy Study of Investigational SHP2 Inhibitor, RMC-4630Additional Poster Presentation to Report New Preclinical Results for Company’s Novel Inhibitors of Oncogenic RAS(ON) mutants… […]

No Picture
News

Neurocrine Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference  Live Audio Webcast will be on January 13, 2020

SAN DIEGO, Jan. 6, 2020 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the 38th Annual J.P. Morgan Healthcare Conference at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time) on Monday, Jan. 13, 2020, in San Francisco. Kev… […]

No Picture
News

Data From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of Perjeta® And Herceptin® Using Halozyme’s ENHANZE® Drug Delivery Technology To Be Presented At San Antonio Breast Cancer Symposium

– Data from Primary Analysis to be Presented in a Spotlight Session Today — Data Expected to be Submitted to U.S. Food and Drug Administration and to the European Medicines Agency in the Near Term –

SAN DIEGO, Dec. 12, 2019 /PRNewswire/ — Halozyme … […]